Immunosuppressive drugs following transplantation | SOP Information, SOPs and Supporting Information – alphabetic listing, C to D, Cardiomyopathy G021, CCPS factors as at 7 March 2007 (G021)

You are here

Immunosuppressive drugs following transplantation

Document

Cardiomyopathy - Immunosuppressive drugs following transplantation Factor

Last reviewed for CCPS 18 July 2007.

Preliminary questions [38017]

38018 there is some evidence that treatment with immunosuppressive drugs following transplantation may be a factor in the development or worsening of the condition under consideration.

38347 the veteran has had a transplantation at some time.

38348the transplantation required the veteran to be treated with immunosuppressive drugs.

38349the transplantation requiring the veteran to be treated with immunosuppressive drugs was for treatment of an illness or injury which is identifiable.

38021the veteran has established the causal connection between treatment with immunosuppressive drugs following transplantation and VEA service for cardiomyopathy.

38028 the veteran was treated with immunosuppressive drugs following a transplantation for the identified illness or injury within the 30 days before the clinical onset of the condition under consideration.

38022the veteran has established the causal connection between treatment with immunosuppressive drugs following transplantation and VEA service for the clinical onset of cardiomyopathy.

38024the veteran has established the causal connection between treatment with immunosuppressive drugs following transplantation and operational service for the clinical onset of cardiomyopathy.

or

38025the veteran has established the causal connection between treatment with immunosuppressive drugs following transplantation and eligible service for the clinical onset of cardiomyopathy.

or

7334

the clinical onset of the condition under consideration occurred after the end of the veteran's last period of VEA service.

7335

the condition under consideration permanently worsened.

38029

the veteran was treated with immunosuppressive drugs following a transplantation for the identified illness or injury within the 30 days before the clinical worsening of the condition under consideration.

38023the veteran has established the causal connection between treatment with immunosuppressive drugs following transplantation and VEA service for the clinical worsening of cardiomyopathy.

38026the veteran has established the causal connection between treatment with immunosuppressive drugs following transplantation and operational service for the clinical worsening of cardiomyopathy.

or

38027the veteran has established the causal connection between treatment with immunosuppressive drugs following transplantation and eligible service for the clinical worsening of cardiomyopathy.

Clinical onset and operational service [38024]

38030the identified illness or injury, for which the veteran had a transplantation that was treated with immunosuppressive drugs, is causally related to operational service.

Clinical onset and eligible service [38025]

38031the identified illness or injury, for which the veteran had a transplantation that was treated with immunosuppressive drugs, is causally related to eligible service.

Clinical worsening and operational service [38026]

38030the identified illness or injury, for which the veteran had a transplantation that was treated with immunosuppressive drugs, is causally related to operational service.

38032

the clinical onset of the condition under consideration occurred prior to that part of operational service to which the identified illness or injury, for which the veteran had a transplantation that was treated with immunosuppressive drugs, is causally related.

Clinical worsening and eligible service [38027]

38031the identified illness or injury, for which the veteran had a transplantation that was treated with immunosuppressive drugs, is causally related to eligible service.

38033

the clinical onset of the condition under consideration occurred prior to that part of eligible service to which the identified illness or injury, for which the veteran had a transplantation that was treated with immunosuppressive drugs, is causally related.